Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000595044 | SCV000708403 | uncertain significance | not provided | 2017-05-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000595044 | SCV001060745 | likely benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000595044 | SCV001989297 | likely pathogenic | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | Identified with the K234R variant on the same allele (in cis) in individuals with relapses in visceral leishmaniasis infection after treatment; the [K234R;R405X] allele was observed in both the heterozygous and homozygous state in the affected individuals and was also heterozygous in unaffected parents (Marquet et al., 2017); Published functional studies on the p.(R405*) variant alone demonstrate a damaging effect on protein expression and cellular activity; when combined with p.(K234R), functional studies demonstrate a more significant reduction in protein expression (Watschinger et al., 2018); Nonsense variant predicted to result in protein truncation as the last 41 amino acids are lost, although loss-of-function variants have not been reported downstream of this position in the protein; This variant is associated with the following publications: (PMID: 28586473, 29741738, 31345219) |